Since lastmany years Saintroy Lifescience is leading manufacture, export andsupplier of Leuprolide Acetate Injectionfrom Surat, Gujarat, India. LeuprolideAcetate Injection used to treat prostate cancer, breast cancer, endometriosis,uterine fibroids, and early puberty, or as part of transgender hormone therapy.
Tags: Leuprolide Acetate Injection manufacturer, Leuprolide AcetateInjection exporter, Leuprolide Acetate Injection supplier, and LeuprolideAcetate Injection, whogmp approved Leuprolide Acetate Injection manufacturerand supplier, Leuprolide Acetate Injection distributor, Leuprolide AcetateInjection shipper, Leuprolide Acetate Injection 3.75 mg Leuprolide AcetateInjection 3.75 mg supplier, Leuprolide AcetateInjection 3.75 mg.
ISO/GMP/cGMP/WHOGMP/NAFDACapproved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturing facilityin Gujarat, India.
Registration: Saintroy Lifescience is interested inregistration of own brand or customer brands in ministry of health ofclients country and we also provide the products samples, COA, COPP, ACTD or CTDossier, DMF, Manufacturing license, Free sales certificate and other requireddocuments.
Export Country :Saintroy Lifescience Leuprolide AcetateInjection export to USA, Canada, Germany, Europe, France, Ghana, Nigeria,Kenya, Senegal, Sudan,UAE, Kuwait, Dubai, Cameroon, Lebanon, Peru, Chile,Somalia, Philippines, Myanmar, Maldives, Thailand, Singapore, Malaysia, HongKong, China, Zimbabwe, Togo, Burkina Faso, Niger,Guinea Bissau, Congo,Democratic of republic, Ivory Costa, Oman, Guatemala, Nicaragua, Salvador,Qatar, Costa Rica, Panama, Cuba, Colombia, Bolivia, Argentine, Algeria, Guyana,Morocco, Jordan, Bahrain, Iran, Egypt, Kyrgyzstan, Uzbekistan, Kazakhstan.